Positions

Principal Investigator On

  • Private Grant  awarded by ORTHO-MCNEIL, INC. 2011 - 2015
  • Private Grant  awarded by Janssen 2013 - 2014
  • Investigator On

  • Private Grant  awarded by LIVANOVA USA, INC. 2020 - 2025
  • Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease(A4 Study)  awarded by University of Southern California 2016 - 2024
  • Combination Anti-Amyloid Therapy for Preclinical Alzheimer's Disease  awarded by University of Southern California 2019 - 2024
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2020 - 2023
  • The A3 Study: Ante-Amyloid Prevention of Alzheimer's Disease  awarded by University of Southern California 2019 - 2023
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. ^ 2020 - 2022
  • A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of 2 Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited Alzheimer’s Disease  awarded by Washington University 2013 - 2022
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC 2020 - 2022
  • AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer’s Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer’s Disease and Intermediate Amyloid (A3 Trial)  awarded by University of Southern California 2020 - 2022
  • Private Grant  awarded by Genentech 2018 - 2022
  • Private Grant  awarded by BIOGEN MA INC 2018 - 2022
  • Alzheimer's Disease Neuroimaging Initiative 3 (ADNl3)  awarded by University of Southern California 2016 - 2022
  • Private Grant  awarded by EISAI, INC. 2013 - 2022
  • A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multicenter Study of Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited Alzheimer’s Disease (“Protocol”).  awarded by Washington University 2018 - 2022
  • Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study  awarded by University of Southern California 2019 - 2021
  • Private Grant  awarded by BIOGEN MA INC 2014 - 2021
  • Private Grant  awarded by Janssen 2016 - 2021
  • Private Grant  awarded by Janssen 2016 - 2021
  • Private Grant  awarded by NEURORX 2020 - 2021
  • Private Grant  awarded by NEURORX 2020 - 2021
  • Augmentation Versus Switch: Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders with Treatment Resistant Depression (ASCERTAIN-TRD)  awarded by PATIENT CENTERED OUTCOMES RESEARCH INSTITUTE 2017 - 2020
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC 2018 - 2020
  • Private Grant  awarded by BIOGEN, INC. 2018 - 2020
  • Private Grant  awarded by ACADIA PHARMACEUTICALS, INC. 2020
  • Private Grant  awarded by ACADIA PHARMACEUTICALS, INC. 2019 - 2020
  • Balanced Placebo Design with Varenicline: Pharmacological and Expectancy Effects on Medication Adherence  awarded by National Institute on Drug Abuse/NIH/DHHS 2018 - 2020
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2016 - 2020
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION - NEW 2019 - 2020
  • Private Grant  awarded by ACADIA PHARMACEUTICALS, INC. 2017 - 2019
  • Private Grant  awarded by BIOGEN, INC. 2016 - 2019
  • Private Grant  awarded by ALLERGAN, INC. 2018 - 2019
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2016 - 2019
  • Private Grant  awarded by ALLERGAN, INC. 2019
  • Private Grant  awarded by INTRA-CELLULAR THERAPIES INC. 2018 - 2019
  • Private Grant  awarded by ALLERGAN SALES, LLC 2017 - 2019
  • Private Grant  awarded by ALLERGAN SALES, LLC 2017 - 2019
  • Private Grant  awarded by NAVITOR PHARMACEUTICALS INC. 2019
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2017 - 2019
  • Private Grant  awarded by NEURORX 2017 - 2019
  • Private Grant  awarded by ALLERGAN SALES, LLC 2017 - 2019
  • Private Grant  awarded by H. LUNDBECK A/S 2014 - 2019
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2015 - 2018
  • A Placebo-Controlled, Crossover Study of Fanapt® (iloperidone) Augmentation of SSRIs for Residual Anger and Irritability in Major Depressive Disorder  awarded by MASSACHUSETTS GENERAL HOSPITAL 2013 - 2018
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2015 - 2018
  • Private Grant  awarded by H. LUNDBECK A/S 2014 - 2018
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2015 - 2018
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2017 - 2018
  • Private Grant  awarded by ALLERGAN, INC. 2016 - 2018
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2015 - 2018
  • Private Grant  awarded by ALKERMES, INC. 2014 - 2017
  • Private Grant  awarded by FOREST LABORATORIES, INC. 2014 - 2017
  • Private Grant  awarded by NAUREX, INC. 2012 - 2017
  • Private Grant  awarded by NAUREX, INC. 2014 - 2017
  • Private Grant  awarded by ALKERMES, INC. 2014 - 2017
  • Private Grant  awarded by TAL MEDICAL 2013 - 2017
  • Private Grant  awarded by GENOMIND 2016
  • Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study: A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial  awarded by University of Southern California 2015 - 2016
  • Alzheimer's Disease Neuroimaging Initiative 2 (ADNI2)  awarded by University of Southern California 2015 - 2016
  • Alzehimer's Disease Neuroimaging Initiative (ADNI)  awarded by University of California, San Diego 2005 - 2016
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC 2012 - 2016
  • Double-Blind, Placebo-Controlled, Proof-of-Concept (POC) Trial of CERC-501, a Kappa-Selective Opioid Receptor Antagonist, Augmentation of Antidepressant Therapy in Treatment-Resistant Depression (TRD)  awarded by MASSACHUSETTS GENERAL HOSPITAL 2015 - 2016
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2014 - 2016
  • Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - The LEARN Study A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial  awarded by University of California, San Diego 2015
  • Private Grant  awarded by ASSUREX HEALTH INC. 2014 - 2015
  • Alzheimer's Disease Cooperative Study  awarded by University of California, San Diego 2013 - 2015
  • Private Grant  awarded by AVANIR PHARMACEUTICALS, INC. 2014 - 2015
  • Private Grant  awarded by TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER 2012 - 2015
  • Private Grant  awarded by TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER 2012 - 2015
  • Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation  awarded by American Foundation for Suicide Prevention 2012 - 2014
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2014
  • Private Grant  awarded by CERECOR, INC. 2013 - 2014
  • Private Grant  awarded by Elan 2012 - 2014
  • 2/2- Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression  awarded by National Institute of Mental Health/NIH/DHHS 2012 - 2014
  • 2/4-A Genomic Approach to Schizophrenia  awarded by National Institute of Mental Health/NIH/DHHS 2009 - 2014
  • Private Grant  awarded by INNOPHARMA, INC. 2013 - 2014
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2012 - 2013
  • Private Grant  awarded by Pfizer Pharmaceuticals 2011 - 2013
  • Private Grant  awarded by Pfizer Pharmaceuticals 2011 - 2013
  • Comparative Effectiveness of a Second Generation Antipsychotic Mood Stabilizer and a Classic Mood Stabilizer for Bipolar Disorder  awarded by MASSACHUSETTS GENERAL HOSPITAL 2012 - 2013
  • Private Grant  awarded by JANSSEN AI (ALZHEIMER IMMUNOTHERAPY) R&D 2008 - 2013
  • Education And Training

  • Master of Education, University of Alabama at Birmingham 1985
  • Bachelor's Degree in Mathematics, University of Alabama 1966
  • Full Name

  • Roberta May